As of Aug 16
| +0.0152 / +4.11%|
The 1 analysts offering 12-month price forecasts for CorMedix Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +1,198.03% increase from the last price of 0.39.
The current consensus among 1 polled investment analysts is to Buy stock in CorMedix Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.